Charge-assisted bond N+H mediates the gelation of amorphous lurasidone hydrochloride during dissolution

Publication date: 25 February 2017 Source:International Journal of Pharmaceutics, Volume 518, Issues 1–2 Author(s): Shuai Qian, Shanshan Wang, Zhen Li, Xiaojie Wang, Di Ma, Shujun Liang, Yuan Gao, Jianjun Zhang, Yuanfeng Wei Lurasidone hydrochloride (LH), the hydrochloride form of lurasidone with a charge-assisted bond N+ H, is an atypical antipsychotropic agent for the treatment of schizophrenia. As a BCS class II drug, LH has a low oral bioavailability mainly due to its poor water solubility and low dissolution. In order to improve its solubility, amorphization of LH was performed and characterized. Unexpectedly, the dissolution rate of amorphous LH was much lower than that of crystalline LH. In addition, the amorphous LH powders quickly aggregated when contacting the dissolution media (water, 37°C), and formed a sticky gel adhering on the paddle. The follow-up polarized light microscope, XRPD, DSC, and FTIR analysis found that amorphous LH transformed to crystalline LH during dissolution. On the other hand, no such gelation phenomenon of amorphous lurasidone was observed under the same dissolution condition. However, the gel would reform when dropping concentrated hydrochloric acid slowly into the bottom of the medium during the dissolution of amorphous lurasidone, and XRPD/DSC/FTIR results indicated that the regenerated gel was consisted of crystalline LH, suggesting that the charge-assisted bond N+ H in the structure of LH mediated the gel formation of amorpho...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research

Related Links:

Changes in hippocampal function are believed to play a role in the onset of psychosis. Astudy published today inJAMA Psychiatry suggests that the concentration of the neurotransmitter glutamate and several other metabolites in the hippocampus may offer clues about patients who are most likely to transition to psychosis.The findings suggest that measuring hippocampal metabolites could help psychiatrists better predict outcomes in patients at risk of developing psychosis.For the study, Matthijs G. Bossong, Ph.D., of the University Medical Center Utrecht in the Netherlands and colleagues used an imaging technique known as pro...
Source: Psychiatr News - Category: Psychiatry Tags: functioning glutamate hippocampus JAMA Psychiatry Juan R. Bustillo Matthijs G. Bossong metabolites proton magnetic resonance spectroscopy psychosis Source Type: research
Genetic variation in glutamatergic or N-methyl-D-aspartate neurotransmission may predict antipsychotic medication response in patients with schizophrenia, a new study shows.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news
Publication date: Available online 13 November 2018Source: Saudi Pharmaceutical JournalAuthor(s): Yong Chon Park, Min-Soo Lee, Tian-Mei Si, Helen F.K. Chiu, Shigenobu Kanba, Mian-Yoon Chong, Adarsh Tripathi, Pichet Udomratn, Kok Yoon Chee, Andi J. Tanra, Golam Rabbani, Afzal Javed, Samudra Kathiarachchi, Win Aung Myint, Tran Van Cuong, Kang Sim, Shu-yu Yang, Norman Sartorius, Chay-Hoon Tan, Naotaka ShinfukuAbstractBackgroundAlthough disorganized speech is seen as one of the nuclear features of schizophrenia, there have been few reports of disorganized speech-associated psychotropic drug-prescribing patterns in large sample...
Source: Saudi Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
In Vietnam, the mental health care infrastructure is on the verge of transformation with an increase in the demand for access to adequate and effective mental health care services. Public attitudes towards men...
Source: International Journal of Mental Health Systems - Category: Psychiatry Authors: Tags: Research Source Type: research
The Bossong et al study titled “Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis” represents an important step forward in the study of glutamatergic abnormalities in the pathophysiology of psychotic disorders. To our knowledge, this is the largest study of in dividuals at clinical high risk to date to use proton magnetic resonance spectroscopy (1H-MRS) and document that those with higher hippocampal glutamate are more likely to transition to psychosis. The hippocampus was selected as the region of interest because hippocampal abnormalities prio...
Source: JAMA Psychiatry - Category: Psychiatry Source Type: research
Authors: DiSciullo AA, English CD, Horn WT Abstract Modafinil has been used as an adjunctive medication in the treatment of bipolar 1 depression with reported success. Case reports have been published demonstrating modafinil induced mania in bipolar patients and modafinil induced psychosis in schizophrenic patients. To our knowledge, we report the only case of modafinil induced psychosis in a patient with bipolar depression treated with both mood stabilizers and antipsychotics. In addition, it is the quickest onset to psychosis (2 days) at the lowest dosage of modafinil (100 mg/day) reported in the literature. Alth...
Source: Case Reports in Psychiatry - Category: Psychiatry Tags: Case Rep Psychiatry Source Type: research
Patrick A. Ho, Danielle N. Dahle, Douglas L. Noordsy
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Zongchang Li, Ying He, Hongying Han, Yao Zhou, Xiaoqian Ma, Dong Wang, Jun Zhou, Honghong Ren, Liu Yuan, Jinsong Tang, Xiaofen Zong, Maolin Hu, Xiaogang Chen
Source: Frontiers in Psychiatry - Category: Psychiatry Source Type: research
Deficits in social functioning in schizophrenia are primarily predicted by negative symptoms, social cognition deficits, and social skills deficits. Here we examine those predictive variables across variations in the severity of reduced emotional experience. We hypothesized that in patients with high symptom severity, factors such as social cognition would have reduced importance for predicting social outcomes.
Source: Schizophrenia Research - Category: Psychiatry Authors: Source Type: research
People with schizophrenia have an increased risk of premature mortality compared to the general population. We aimed to quantify which types of causes of death contributed to the excess mortality, and to examine whether there has been an increase in the excess mortality among persons with schizophrenia in the period 1995 to 2015.
Source: Schizophrenia Research - Category: Psychiatry Authors: Source Type: research
More News: Drugs & Pharmacology | Schizophrenia